Grän F, Kerstan A, Serfling E et al (2020) Current developments in the immunology of psoriasis. Yale J Biol Med 93:97–110

PubMed  PubMed Central  Google Scholar 

Tokuyama M, Mabuchi T (2020) New treatment addressing the pathogenesis of psoriasis. Int J Mol Sci 21:7488

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rendon A, Schäkel K (2019) Psoriasis pathogenesis and treatment. Int J Mol Sci 20:1475

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ozaras R, Berk A, Ucar DH et al (2020) Covid‐19 and exacerbation of psoriasis. Dermatol Ther 33. https://doi.org/10.1111/dth.13632

Recalcati S (2020) Cutaneous manifestations in COVID‐19: a first perspective. J Eur Acad Dermatol Venereol 34. https://doi.org/10.1111/jdv.16387

Mathieu RJ, Cobb CBC, Telang GH et al (2020) New-onset pustular psoriasis in the setting of severe acute respiratory syndrome coronavirus 2 infection causing coronavirus disease 2019. JAAD Case Rep 6:1360–1362

Article  PubMed  PubMed Central  Google Scholar 

Patrick MT, Zhang H, Wasikowski R et al (2021) Associations between COVID-19 and skin conditions identified through epidemiology and genomic studies. J Allergy Clin Immunol 147:857-869.e7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aram K, Patil A, Goldust M et al (2021) COVID-19 and exacerbation of dermatological diseases: a review of the available literature. Dermatol Ther 34(6):e15113. https://doi.org/10.1111/dth.15113

Article  CAS  PubMed  PubMed Central  Google Scholar 

Skrek S, Di Lernia V, Beauchet A et al (2023) Clinical and epidemiological features of psoriasis exacerbations in children with SARS-CoV-2 infection. J Eur Acad Dermatol Venereol 37(10):e1192–e1195. https://doi.org/10.1111/jdv.19261

Article  CAS  PubMed  Google Scholar 

Zanza C, Romenskaya T, Manetti AC et al (2022) Cytokine storm in COVID-19: immunopathogenesis and therapy. Medicina (B Aires) 58:144

Article  Google Scholar 

Huang Z, Xie N, Illes P et al (2021) From purines to purinergic signalling: molecular functions and human diseases. Signal Transduct Target Ther 6:162

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zarei M, SahebiVaighan N, Ziai SA (2021) Purinergic receptor ligands: the cytokine storm attenuators, potential therapeutic agents for the treatment of COVID-19. Immunopharmacol Immunotoxicol 43:633–643

Article  CAS  PubMed  Google Scholar 

Leão Batista Simões J, Fornari Basso H, CristineKosvoski G et al (2021) Targeting purinergic receptors to suppress the cytokine storm induced by SARS-CoV-2 infection in pulmonary tissue. Int Immunopharmacol 100:108150

Article  PubMed  PubMed Central  Google Scholar 

Hasan D, Shono A, van Kalken CK et al (2022) A novel definition and treatment of hyperinflammation in COVID-19 based on purinergic signalling. Purinergic Signal 18:13–59

Article  CAS  PubMed  Google Scholar 

Lowes MA, Suárez-Fariñas M, Krueger JG (2014) Immunology of psoriasis. Annu Rev Immunol 32:227–255

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mahil SK, Capon F, Barker JN (2016) Update on psoriasis immunopathogenesis and targeted immunotherapy. Semin Immunopathol 38:11–27

Article  CAS  PubMed  Google Scholar 

Singh R, Koppu S, Perche PO et al (2021) The cytokine mediated molecular pathophysiology of psoriasis and its clinical implications. Int J Mol Sci 22:12793

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yan D, Gudjonsson JE, Le S et al (2021) New frontiers in psoriatic disease research, part I: genetics, environmental triggers, immunology, pathophysiology, and precision medicine. J Investig Dermatol 141:2112-2122.e3

Article  CAS  PubMed  Google Scholar 

Blauvelt A, Chiricozzi A (2018) The immunologic role of IL-17 in psoriasis and psoriatic arthritis pathogenesis. Clin Rev Allergy Immunol 55:379–390

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schön MP (2019) Adaptive and innate immunity in psoriasis and other inflammatory disorders. Front Immunol 10:1764. https://doi.org/10.3389/fimmu.2019.01764

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kutwin M, Woźniacka A (2023) Interleukins 20 and 8 – less widely known cytokines in psoriasis. Adv Dermatol Allergol 40:194–203

Article  Google Scholar 

Nickoloff BJ, Qin J-Z, Nestle FO (2007) Immunopathogenesis of psoriasis. Clin Rev Allergy Immunol 33:45–56

Article  CAS  PubMed  Google Scholar 

Han L, Sugiyama H, Zhang Q et al (2018) Phenotypical analysis of ectoenzymes CD39/CD73 and adenosine receptor 2A in CD4+ CD25high Foxp3 + regulatory T-cells in psoriasis. Australas J Dermatol 59(1):e31–e38. https://doi.org/10.1111/ajd.12561

Article  PubMed  Google Scholar 

Sugiyama H, Gyulai R, Toichi E et al (2005) Dysfunctional blood and target tissue CD4+CD25 high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation. J Immunol 174:164–173

Article  CAS  PubMed  Google Scholar 

Lanna C, Mancini M, Gaziano R et al (2019) Skin immunity and its dysregulation in psoriasis. Cell Cycle 18:2581–2589

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marina ME, Roman II, Constantin A-M et al (2015) VEGF involvement in psoriasis. Med Pharm Rep 88:247–252

Google Scholar 

Elias PM, Arbiser J, Brown BE et al (2008) Epidermal vascular endothelial growth factor production is required for permeability barrier homeostasis, dermal angiogenesis, and the development of epidermal hyperplasia. Am J Pathol 173:689–699

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kaliyadan F (2018) The dermoscopic auspitz sign. Indian Dermatol Online J 9:290

Article  PubMed  PubMed Central  Google Scholar 

Valdimarsson H, Thorleifsdottir RH, Sigurdardottir SL et al (2009) Psoriasis – as an autoimmune disease caused by molecular mimicry. Trends Immunol 30:494–501

Article  CAS  PubMed  Google Scholar 

Alshamrani S, Mashraqi MM, Alzamami A et al (2023) Mining autoimmune-disorder-linked molecular-mimicry candidates in clostridioides difficile and prospects of mimic-based vaccine design: an in silico approach. Microorganisms 11:2300

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shakoei S, Ghanadan A, Hamzelou S (2020) Pustular psoriasis exacerbated by COVID‐19 in a patient with the history of psoriasis. Dermatol Ther 33. https://doi.org/10.1111/dth.14462

Agharbi FZ, Basri G, Nejjari S et al (2024) Erythrodermic psoriasis following SARS-CoV-2 infection. Actas Dermosifiliogr 115:202–203

Article  CAS  PubMed  Google Scholar 

Wu M, Teymour S, Ashinoff R et al (2022) Psoriasiform dermatitis in a COVID-19 patient. Case Rep Dermatol Med 2022:1–3

Google Scholar 

Lane JB, Stahly S, Sills A, et al (2022) Examination of cutaneous changes among patients following SARS-CoV-2 infection. Cureus.